Receive our newsletter – data, insights and analysis delivered to you
  1. Market Data
April 14, 2016

Deals this week: GE Ventures, Shanghai Fosun Pharma, Cambrooke Therapeutics

GE Ventures and Mayo Clinic have created a new joint venture (JV) company called Vitruvian Networks, Inc., which will expedite the treatment of cancer and other diseases by providing therapy producers in these areas with modern software systems and manufacturing services.

Mayo Clinic

GE Ventures and Mayo Clinic have created a new joint venture (JV) company called Vitruvian Networks, Inc., which will expedite the treatment of cancer and other diseases by providing therapy producers in these areas with modern software systems and manufacturing services.

Vitruvian Networks will use Mayo Clinic’s data related to biomarkers, cell therapy processes and leverage GE Healthcare’s cell therapy business tools to develop personalised therapies.

"The company will raise approximately $928m through placement of renewable corporate bonds to qualified private investors."

Shanghai Fosun Pharma has announced new fund raising plan for replenishing its working capital and pay off existing loans.

The company will raise approximately $928m through placement of renewable corporate bonds to qualified private investors.

Cambrooke Therapeutics has completed a series C financing round for its global expansion and entry into other disease states.

The deal was led by Seventure Partners and also included Galen Partners and co-investors from Europe and the US.

Content from our partners
Extractables and leachables analysis in pharmaceutical quality control
How Hengst helped to keep Germany’s charity “star singers” shining

Image: GE Ventures and Mayo Clinic have created a new joint venture (JV) company called Vitruvian Networks: Photo: Courtesy:Micheal Hicks

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU